Search

Le Tourneau, Christophe

P630

A PHASE I STUDY OF RADIATION ENHANCING FUNCTIONALIZED HAFNIUM OXIDE NANOPARTICLES IN CISPLATIN-INELIGIBLE PATIENTS WITH LOCALLY ADVANCED HNSCC

Radiation / Adjuvant Treatment

Christophe Le Tourneau, MD, PhD1; Valentin Calugaru, MD, PhD1; Edith Borcoman, MD1; Zoltan Takacsi-Nagy, MD, PhD2; Xavier Liem, MD3; Zsuzsanna Papai, MD, PhD4; Jacek Fijuth, MD, PhD5; Victor Moreno, MD6; Irene Braña, MD, PhD7; Sébastien Salas, MD, PhD8; Gilles Poissonnet, MD9; Emiliano Calvo, MD, PhD10; Bernard Doger, MD6; Olivier Choussy, MD1; Maria Lesnik, MD1; Xavier Mirabel, MD3; Nathalie Badois, MD1; Samar Krhili, MD1; Katell Bernois11; Nicolas Fakhry, MD, PhD8; Stéphanie Wong Hee Kam, MD8; Caroline Hoffmann, MD, PhD1

1Institut Curie, Paris, France; 2National Institute of Oncology, Budapest, Hungary; 3Oscar Lambret Center, Lille, France; 4Hungarian Defense Forces Medical Center, Budapest, Hungary; 5Medical University of Lodz, Lodz, Poland; 6START - Fundación Jiménez Díaz, Madrid, Spain; 7Val d'Hebron Institut of Oncology, Barcelona, Spain; 8Hôpital Timone, Marseille, France; 9Unicancer, CLC Antoine Lacassagne, Nice, France; 10START - HM Sanchinarro University Hospital, Madrid, Spain; 11Nanobiotix S.A., Paris, France